Sign in to view content

Baseline Characteristics of Patients Who Did or Did Not Maintain 12-Week and 16-Week Aflibercept 8 mg Dosing Intervals in the Phase 2/3 PHOTON Trial

Eric W Schneider, MD

Video
Published 2023

Related

Bilateral Cystoid Macular Edema in a Nine-Year-Old With a Giant Arachnoid Cyst in the Cerebellar Fossa
Armando G. Sandoval, MD
On Demand Cases, Courses, and Papers
2019
Risk for Sight-Threatening Diabetic Retinopathy With GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes
Andrew J. Barkmeier, MD
Annual Meeting Talks
2024
Clinical Trials Handbook
Nikolas JS London, MD, FACS, FASRS
Updates from the Field
2021

Category: Diabetic Retinopathy

See more